Warfarin anticoagulation intensity in Japanese nonvalvular atrial fibrillation patients: A J-RHYTHM Registry analysis

Journal of Cardiology

Volumn 65, Issue 3, 2015, Pages 175-177

  Yamashita, Takeshi ^a   Inoue, Hiroshi ^b   Okumura, Ken ^c   Atarashi, Hirotsugu ^d   Origasa, Hideki ^b  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; INR; Intracranial hemorrhage; Stroke; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHADS2 SCORE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONVALVULAR ATRIAL FIBRILLATION; PREVALENCE; REGISTER; SYSTEMIC EMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; ATRIAL FIBRILLATION; CHEMICALLY INDUCED; COMPLICATION; EMBOLISM; ETHNOLOGY; HEMORRHAGE; INTRACRANIAL HEMORRHAGES; JAPAN; MIDDLE AGED; ODDS RATIO; RISK; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; EMBOLISM; FEMALE; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RISK; STROKE; WARFARIN;

EID: 84924271673     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.07.013     Document Type: Article

References (11)

1. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith S.C., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e257-e354.
2. Shen A.Y., Yao J.F., Brar S.S., Jorgensen M.B., Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007, 50:309-315.
3. Hori M., Matsumoto M., Tanahashi N., Momomura S., Uchiyama S., Goto S., Izumi T., Koretsune Y., Kajikawa M., Kato M., Ueda H., Iwamoto K., Tajiri M. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation the J-ROCKET AF study. Circ J 2012, 76:2104-2111.
4. Atarashi H., Inoue H., Okumura K., Yamashita T., Origasa H. Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation - the J-RHYTHM Registry study design. J Cardiol 2011, 57:95-99. J-RHYTHM Registry Investigators.
5. Atarashi H., Inoue H., Okumura K., Yamashita T., Kumagai N., Origasa H. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011, 75:1328-1333. J-RHYTHM Registry Investigators.
6. Inoue H., Okumura K., Atarashi H., Yamashita T., Origasa H., Kumagai N., Sakurai M., Kawamura Y., Kubota I., Matsumoto K., Kaneko Y., Ogawa S., Aizawa Y., Chinushi M., Kodama I., et al. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry. Circ J 2013, 77:2264-2270.
7. Hylek E.M., Skates S.J., Sheehan M.A., Singer D.E. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996, 335:540-546.
8. Hylek E.M., Singer D.E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994, 120:897-902.
9. Yasaka M., Minematsu K., Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001, 40:1183-1188.
10. Naganuma M., Shiga T., Sato K., Murasaki K., Hashiguchi M., Mochizuki M., Hagiwara N. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study. Thromb Res 2012, 130:21-26.
11. Akao M., Chun Y.H., Wada H., Esato M., Hashimoto T., Abe M., Hasegawa K., Tsuji H., Furuke K. Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry. J Cardiol 2013, 61:260-266. Fushimi AF Registry Investigators.